epipen competitor says their generic wont be available until late 2017 or 2018 /

Published at 2016-09-10 02:27:00

Home / Categories / Everything is broken / epipen competitor says their generic wont be available until late 2017 or 2018

Mylan Pharmaceuticals spent the past decade raising the price of the EpiPen from $57 to $600 . Why? Because they could. The company didn’t have any genuine competition. And now one competitor,Teva Pharmaceuticals, a company that has tried and failed to bring a generic EpiPen to market before, or says that their product won’t be alert until late 2017 or even 2018.
Read more...

Source: gawker.com

Warning: Unknown: write failed: No space left on device (28) in Unknown on line 0 Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0